Issues Raised by Human Cloning Research (2001)
Hearing of the United States, Congress, House, Committee on Energy and Commerce, Subcommittee on Oversight and Investigations. Witnesses at the hearing: Panel 1: Dr. Thomas B. Okarma, President and CEO Geron Corporation; Dr. Rudolf Jaenishch, Professor of Biology, Massachusetts Institute of Technology; Dr. Brigitte Boisselie, Visiting Assistant Professor Chemistry and Chemist for CloneAid; Dr. Mark E. Westhusin, Associate Professor, Texas A&M University, College of Veterinary Medicine; Dr. Panos Michael Zovos, Founder, Director and Chief Andrologist, Andrology Institute of America Pane 2: Dr. Thomas Murray, National Bioethics Advisory Commission; Dr. Kathryn C. Zoon, Director, Center for biologics Evaluation and Research, Food and Drug Administration Panel 3: Dr. Gregory Pence, Professor of Philosophy, School of Medicine & Humanities, University of Alabama at Birmingham; Mr. Randolphe H. Wicker, Founder, Clone Rights United Front; Dr. Arthur L. Caplan, Director, Center for Bioethics, University of Pennsylvania; Dr. Sharon Terry, Genetics Alliance, Inc.; Dr. Nigel M. De S. Cameron, Principal, Strategic Futures Group, LLC; Dr. Michale Soules, President, American Society of Reproductive Medicine; Rael, Leader of the Raelian Movement; Mr. Jaydee Hanson, Assistant General Secretary, The United Methodist Church; Mr. Mark Donald Eibert
Showing items related by title, author, creator and subject.
Producer: National Cable Satellite Corporation (2001-08-07)"Professors talked about the ethics of human cloning for both therapeutic and reproductive reasons. Among the topics they addressed were methods of cloning, potential dangers involved, and potential benefits of cloning. ...
Producer: National Cable Satellite Corporation. C-SPAN (2001-08-07)The scientists provided background information on a variety of topics, including embryology, scientific issues underlying cloning, and the role of mitochondria. After their presentations, the scientists answered questions ...
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (2001-03-28)